Jeeyeon Baik
Impact in
-
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 8
- Oncology 8
- CAR-T cell therapy research 6
- Co-authors
- Mikhail Roshal (15 shared papers)Wenbin Xiao (12 shared papers)Ahmet Doǧan (13 shared papers)Yanming Zhang (10 shared papers)Maria E. Arcila (8 shared papers)Qi Gao (8 shared papers)Natasha Lewis (6 shared papers)Alison J. Moskowitz (4 shared papers)
- Journals
- Blood (7 papers)Cytometry Part B Clinical Cytometry (3 papers)Blood Advances (2 papers)HemaSphere (1 paper)Molecular Case Studies (1 paper)
- Partner nations
- United StatesSingaporeFrance
In The Last Decade
Jeeyeon Baik
15 papers receiving 150 citations
Peers
Comparison fields: 5 of 29
- Hematology 61
- Pathology and Forensic Medicine 73
- Dermatology 26
- Genetics 31
- Oncology 76
Countries citing papers authored by Jeeyeon Baik
This map shows the geographic impact of Jeeyeon Baik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeeyeon Baik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeeyeon Baik more than expected).
Fields of papers citing papers by Jeeyeon Baik
This network shows the impact of papers produced by Jeeyeon Baik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeeyeon Baik. The network helps show where Jeeyeon Baik may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeeyeon Baik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 66 | |
| 2 | 2020 | 26 | |
| 3 | 2020 | 18 | |
| 4 | 2019 | 8 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 6 | |
| 7 | 2018 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2018 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2019 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2023 | 0 |
About Jeeyeon Baik
Jeeyeon Baik is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Immunology and Genetics, having authored 18 papers that have together received 151 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Hematology (61 citations), Pathology and Forensic Medicine (73 citations), Dermatology (26 citations), Genetics (31 citations) and Oncology (76 citations). Jeeyeon Baik has collaborated with scholars based in United States, Singapore and France. Frequent co-authors include Mikhail Roshal, Wenbin Xiao, Ahmet Doǧan, Yanming Zhang, Maria E. Arcila, Qi Gao, Natasha Lewis, Alison J. Moskowitz, Kseniya Petrova‐Drus and Steven M. Horwitz. Their work appears in journals such as Blood, Cytometry Part B Clinical Cytometry, Blood Advances, HemaSphere and Molecular Case Studies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.